Pregled bibliografske jedinice broj: 225491
The influence of dopamine receptor agonists and an antagonist on acute pancreatitis in rats
The influence of dopamine receptor agonists and an antagonist on acute pancreatitis in rats // European journal of pharmacology, 147 (1988), 3; 321-326 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 225491 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The influence of dopamine receptor agonists and an antagonist on acute pancreatitis in rats
Autori
Sikirić, Predrag ; Rotkvić, Ivo ; Miše, Stjepan ; Križanac, Šimun ; Gjurić, Veljko ; Jagić, Vjekoslav ; Suchanek, Ernest ; Petek, Marijan ; Udovičić, Ivan ; Geber, Juraj ; Tućan-Foretić, Milica ; Cvitanović, Branimir ; Ivanović, Dragutin ; Marović, Anton
Izvornik
European journal of pharmacology (0014-2999) 147
(1988), 3;
321-326
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Pancreatitis (acute); Dopamine receptor agonists; Dopamine receptor antagonists; Bromocriptine; Amantadine; Domperidone; (Protection; Aggravation)
Sažetak
The influence of the dopamine receptor-stimulating agent, bromocriptine, the dopamine-releasing drug, amantadine, and the dopamine antagonist, domperidone, on acute pancreatitis was studied in rats. Acute pancreatitis was induced by ligation of the bile duct at its point of entry into the duodenum. Each drug was applied intraperitoneally 1 h before induction of acute pancreatitis and all the surviving animals were killed 24 h thereafter. The control, saline-pretreated animals exhibited the mortality rate, macroscopical and histological changes, as well as increase of serum amylase levels that were consistent with acute pancreatitis. Domperidone induced a large increase in serum amylase which was significantly reduced by the simultaneous administration of bromocriptine. However, both bromocriptine and amantadine, when given separately did not prevent the increase of serum amylase levels to the control levels. Statistical analysis showed that the difference the mortality rate in the control and treated groups did not reach the level of significance probably due to the rather limited number of animals used. On the other hand, application of bromocriptine as well as amantadine successfully reduced the onset of acute pancreatitis whereas domperidone, a rather specific peripheral dopamine receptor blocker, had the opposite effect. Both bromocriptine and amantadine significantly reduced the mortality rate from acute pancreatitis in domperidone-pretreated rats. Since the aggravating effect of domperidone was successfully reduced by simultaneous application of bromocriptine, we think that these effects are mediated by peripheral dopamine receptors. However, the mechanisms whereby dopamine receptor-stimulating and dopamine-releasing drugs produce their beneficial effects remain to be elucidated.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Anton Marović
(autor)
Branimir Cvitanović
(autor)
Ivo Rotkvić
(autor)
Milica Tućan-Foretić
(autor)
Marijan Petek
(autor)
Stjepan Miše
(autor)
Šimun Križanac
(autor)
Juraj Geber
(autor)
Vjekoslav Jagić
(autor)
Ivan Udovičić
(autor)
Predrag Sikirić
(autor)
Ernest Suchanek
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE